Immunogenicity and Safety of Tetravalent Dengue Vaccine (TDV) at the End of Shelf Life in Healthy Adults

Condition:   Dengue Fever Intervention:   Biological: Takeda's Tetravalent Dengue Vaccine Candidate (TDV) Sponsor:   Takeda Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials